FDA Approved: PREGABALIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves the supplemental ANDA for pregabalin from Aurobindo Pharma Limited, enabling the marketing of a generic pregabalin product in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Fibromyalgia
• Generalized Anxiety Disorder
• Partial-onset Seizures
• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)